Atlas Trials

Methotrexate or Thiotepa Combined With R-CHOP and Orelabrutinib in CNSL Patients

Clinical trial NCT06901999 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06901999
Sponsor
Ruijin Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
CNS Lymphoma
Start date
2025-04-01
Primary completion
2026-11-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.